ATE284688T1 - Feromone enthaltende zusammensetzung zur minderung von stress, angst und streitsucht in schweine - Google Patents

Feromone enthaltende zusammensetzung zur minderung von stress, angst und streitsucht in schweine

Info

Publication number
ATE284688T1
ATE284688T1 AT99903663T AT99903663T ATE284688T1 AT E284688 T1 ATE284688 T1 AT E284688T1 AT 99903663 T AT99903663 T AT 99903663T AT 99903663 T AT99903663 T AT 99903663T AT E284688 T1 ATE284688 T1 AT E284688T1
Authority
AT
Austria
Prior art keywords
anxiety
feromones
contradiction
pigs
composition containing
Prior art date
Application number
AT99903663T
Other languages
English (en)
Inventor
Patrick Pageat
Original Assignee
Fideline
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31950877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE284688(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fideline filed Critical Fideline
Application granted granted Critical
Publication of ATE284688T1 publication Critical patent/ATE284688T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Compounds Of Iron (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Inorganic Insulating Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT99903663T 1998-01-21 1999-01-21 Feromone enthaltende zusammensetzung zur minderung von stress, angst und streitsucht in schweine ATE284688T1 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP98400117A EP0948963B1 (de) 1998-01-21 1998-01-21 Pheromone enthaltende Zusammensetzung zur Minderung von Stress, Angst und Streitsucht in Schweinen
CA2227706A CA2227706C (en) 1998-01-21 1998-01-21 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
US09/010,515 US6077867A (en) 1998-01-21 1998-01-21 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
NO980282A NO308197B1 (no) 1998-01-21 1998-01-21 Sammensetning og oppløsning derav for Õ minske stress, angst og agressivitet hos pattedyr inneholdende en blanding av fettsyrer eller derivater derav
JP00980298A JP4750232B2 (ja) 1998-01-21 1998-01-21 ストレス、不安および攻撃性を低減するブタ鎮静フェロモン
CZ20002700A CZ20002700A3 (cs) 1998-01-21 1999-01-21 Uklidňující feromonové prostředky pro snížení stresu, úzkosti a agresivity prasat
PCT/EP1999/000375 WO1999037297A1 (en) 1998-01-21 1999-01-21 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness

Publications (1)

Publication Number Publication Date
ATE284688T1 true ATE284688T1 (de) 2005-01-15

Family

ID=31950877

Family Applications (2)

Application Number Title Priority Date Filing Date
AT98400117T ATE239464T1 (de) 1998-01-21 1998-01-21 Pheromone enthaltende zusammensetzung zur minderung von stress, angst und streitsucht in schweinen
AT99903663T ATE284688T1 (de) 1998-01-21 1999-01-21 Feromone enthaltende zusammensetzung zur minderung von stress, angst und streitsucht in schweine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT98400117T ATE239464T1 (de) 1998-01-21 1998-01-21 Pheromone enthaltende zusammensetzung zur minderung von stress, angst und streitsucht in schweinen

Country Status (21)

Country Link
US (2) US6077867A (de)
EP (2) EP0948963B1 (de)
JP (1) JP4750232B2 (de)
CN (1) CN1217659C (de)
AT (2) ATE239464T1 (de)
AU (1) AU760614B2 (de)
BR (1) BRPI9907151C1 (de)
CA (2) CA2227706C (de)
CZ (1) CZ20002700A3 (de)
DE (2) DE69814343T2 (de)
DK (2) DK0948963T3 (de)
ES (2) ES2198661T3 (de)
HU (1) HU226882B1 (de)
IL (1) IL137257A0 (de)
NO (2) NO308197B1 (de)
NZ (1) NZ505813A (de)
PL (1) PL199144B1 (de)
PT (2) PT948963E (de)
SK (1) SK285905B6 (de)
WO (1) WO1999037297A1 (de)
ZA (1) ZA99426B (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323237B1 (en) * 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US20090253781A1 (en) * 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
JP4754688B2 (ja) * 1998-01-21 2011-08-24 フィドゥラン ストレス、不安及び攻撃性を低減するブタ鎮静フェロモン
US6054481A (en) * 1998-01-21 2000-04-25 Fideline Pig appeasing pheromones for enhancing weight gain in a mammal
CA2704975A1 (en) * 1999-10-13 2001-05-31 Marco A. Chacon Therapeutic intervention to mimic the effect of caloric restriction
MXPA03000359A (es) * 2000-07-14 2003-05-27 Nestle Sa Lipidos de la dieta para mejorar la piel y el pelaje de mascotas.
FR2815227B1 (fr) * 2000-10-17 2003-04-11 Schwartz Laboratoires Robert Composition anti-stress destinee a etre incorporee principalement a des vehicules nutritionnels
ES2186576B1 (es) * 2001-10-11 2004-09-16 Universitat De Les Illes Balears Acido 2-hidroxioleico para utilizar como medicamento.
MXPA04013005A (es) * 2002-06-19 2005-09-12 Fideline Feromonas tranquilizantes de aves para reducir estres, ansiedad y agresividad.
DE60332635D1 (de) * 2002-06-19 2010-07-01 Fideline Le Rieu Neuf Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität
KR100700884B1 (ko) 2002-11-14 2007-03-29 백융기 약학적으로 유용한 노화 및 스트레스 조절용 신규 페로몬 화합물 및 그 분리정제방법
GB0420856D0 (en) * 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
NZ551782A (en) 2004-06-03 2010-03-26 Athlomics Pty Ltd Agents and methods for diagnosing stress
WO2006020137A2 (en) * 2004-07-16 2006-02-23 Ketocytonyx Inc. Oligomeric compounds
EP1778615A4 (de) * 2004-07-20 2010-01-06 Btg Int Ltd Oligomere ketonverbindungen
US20070225252A1 (en) * 2004-07-23 2007-09-27 Gross Richard A Ketogenic Saccharides
ES2574557T3 (es) * 2004-09-21 2016-06-20 Btg International Limited Miméticos dopaminérgicos
EP1793813A4 (de) * 2004-09-21 2011-05-18 Btg Int Ltd Behandlung von adhd
US20090275670A1 (en) * 2008-04-30 2009-11-05 Marshall Gerald L Dog pheromone formulation and delivery system
FR2931676B1 (fr) * 2008-05-30 2011-01-14 Ceva Sante Animale Nouveaux modes d'administration d'un melange d'acides gras pour le traitement de mammiferes non humains
MX2011002895A (es) 2008-09-18 2011-04-11 Janssen Pharmaceutica Nv Uso de azaperona para reducir el uso de antibioticos.
CA2731684C (en) 2008-10-16 2013-11-26 Prolec-Ge Internacional, S. De R.L. De C.V. Vegetable oil of high dielectric purity, method for obtaining same and use in an electrical device
US9750903B2 (en) * 2008-12-30 2017-09-05 Gearbox, Llc Method for administering an inhalable compound
US8871190B2 (en) 2009-04-25 2014-10-28 Sergeant's Pet Care Products, Inc. Polymeric pheromone formulation and method of use to calm stress-related behavior in mammals over an extended period of time
EP2515647B1 (de) * 2009-12-21 2014-01-29 Sergeant's Pet Care Products, Inc. Pheromonzusammensetzungen und verfahren zu ihrer verwendung
CN103126886A (zh) * 2011-05-13 2013-06-05 中国农业科学院北京畜牧兽医研究所 一种仔猪安抚剂释放盒
CN102240279B (zh) * 2011-05-13 2013-04-10 中国农业科学院北京畜牧兽医研究所 一种仔猪安抚剂及其制备方法和应用
HUE039129T2 (hu) * 2011-09-20 2018-12-28 Sergeants Pet Care Products Inc Interomon készítmények és alkalmazásuk különbözõ gerinces fajok viselkedésének megváltoztatására
US9480688B2 (en) 2011-09-20 2016-11-01 Sergeant's Pet Care Products, Inc. Pheromone compositions and their use to modify behavior in different vertebrate species
US9314018B2 (en) 2012-06-25 2016-04-19 Institut de Recherche en Semiochimie et Ethologie Appliquee Feline scratch marking semiochemicals
PT3119198T (pt) 2014-03-18 2020-07-13 Institut De Rech En Semiochimie Et Ethologie Appliquee Composições semioquímicas para reduzir conflitos sociais com gatos
JP6629286B2 (ja) * 2014-03-18 2020-01-15 アンスティテュ・ドゥ・ルシェルシュ・アン・セミオシミー・エ・エソロジー・アプリケＩｎｓｔｉｔｕｔ Ｄｅ Ｒｅｃｈｅｒｃｈｅ Ｅｎ Ｓｅｍｉｏｃｈｉｍｉｅ Ｅｔ Ｅｔｈｏｌｏｇｉｅ Ａｐｐｌｉｑｕｅｅ ネコ鎮静フェロモン
EP2926809A1 (de) 2014-03-31 2015-10-07 Ceva Sante Animale Zusammensetzungen auf Pheromonbasis zur Behandlung von stressbedingten Verhaltensproblemen oder medizinischen Problemen von nicht-humanen Säugetieren
FR3031039B1 (fr) 2014-12-24 2018-03-02 Virbac Composition apaisante pour animaux comprenant au moins un acide gras et de la nepetalactone
FR3031104B1 (fr) 2014-12-26 2017-01-06 Melchior Material & Life Science France Composition pro-pheromonale apaisante pour les mammiferes
WO2016115607A1 (en) 2015-01-23 2016-07-28 Pork Crc Ltd Product and method for providing enrichment and facilitating expression of natural behaviours in pigs
AU2016221929A1 (en) * 2015-02-20 2017-07-13 Société des Produits Nestlé S.A. Medium chain fatty acids and their triglycerides for treating anxiety
EP3124020A1 (de) 2015-07-31 2017-02-01 Ceva Sante Animale Pheromonzusammensetzungen und verwendungen davon
FR3046334B1 (fr) 2015-12-31 2020-03-06 Melchior Material And Life Science France Composition solide pour le relargage controle de substances semiochimiques
AU2018354090B2 (en) 2017-10-23 2024-10-24 Epitracker, Inc. Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome
KR101994338B1 (ko) * 2017-10-25 2019-06-28 엘지이노텍 주식회사 사육장 관리 장치 및 방법
EP3727457B1 (de) 2017-12-22 2025-08-20 Ceva Santé Animale Verteiler für zusammensetzung aus semiochemikalien, die über die temperatur reguliert werden
AU2019274431B2 (en) 2018-05-23 2025-03-13 Epitracker, Inc. Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity
EP3908374A4 (de) 2019-01-09 2022-12-28 Epitracker, Inc. Zusammensetzungen und verfahren zur diagnose und behandlung von neurodegenerativen erkrankungen
WO2020180814A1 (en) 2019-03-04 2020-09-10 Epitracker, Inc. Fatty acid analogs and their use in the treatment of cognitive impairment, behavioral conditions, and chronic pain
BR112022004898A2 (pt) 2019-09-19 2022-06-07 J Mcglone John Feromônio neonatal materno de suíno
WO2021165279A1 (en) 2020-02-19 2021-08-26 Marel Meat A/S Method and system for pre-stunning and/or stunning animals
EP4199751A4 (de) * 2020-08-20 2024-09-04 Epitracker, Inc. Zusammensetzungen und verfahren zur stimmungsverbesserung
AU2021367318A1 (en) * 2020-10-19 2023-06-08 Oregon State University Methods for treating autism spectrum disorder
CN112370528B (zh) * 2020-10-23 2022-04-08 宁波三生生物科技股份有限公司 一种具标识功能的信息素组合物及其制剂
EP4426130A1 (de) 2021-11-03 2024-09-11 Epitracker, Inc. Pentadecanoylcarnitin zur behandlung von alterungs- und langlebigkeitsbedingten leiden
CN114452238B (zh) * 2022-01-07 2023-10-27 佛山市南海东方澳龙制药有限公司 具有安抚作用的宠物药浴香波及其制备方法
CN118843460A (zh) * 2022-03-14 2024-10-25 Fera诊断和生物制品公司 脂肪酸组合物
CN117322521A (zh) * 2023-10-20 2024-01-02 中国农业大学 十五烷酸在缓解动物断奶应激中的应用
CN117919345A (zh) * 2023-12-21 2024-04-26 宁波三生生物科技股份有限公司 一种信息素组合物及其制备方法
EP4595749A1 (de) 2024-02-02 2025-08-06 Signs Verfahren zur freisetzung eines semiochemischen stoffes in der umgebung durch passive diffusion, system und mittel, insbesondere stifte, an diesem ende und verwendungen davon
CN120938981A (zh) * 2025-10-20 2025-11-14 宁波三生生物科技股份有限公司 一种信息素组合物及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61249371A (ja) * 1985-04-30 1986-11-06 Nippon Oil & Fats Co Ltd 栄養飲料組成物
JP3039817B2 (ja) * 1990-09-28 2000-05-08 株式会社資生堂 シャンプー組成物
ES2034888B1 (es) * 1991-07-11 1994-02-16 Madaus Cerafarm Lab Procedimiento de obtencion de la fraccion acida total de los extractos lipidicos de los frutos del sabal serrulata.
US5425963A (en) * 1991-09-17 1995-06-20 Church & Dwight Co., Inc. High purity fatty acid salt products
WO1993011987A1 (fr) * 1991-12-13 1993-06-24 Viktor Nikolaevich Kizilov Vehicule sur coussin d'air
SE9200541D0 (sv) * 1992-02-24 1992-02-24 Kabi Pharmacia Ab New usee of omega-3-fatty acids
WO1993018667A1 (en) * 1992-03-20 1993-09-30 Church & Dwight Company, Inc. Encapsulated dietary fatty acid salt products
DE69420124T2 (de) * 1993-01-15 2000-03-02 Abbott Laboratories, Abbott Park Strukturierte lipide
DE69512509T2 (de) * 1995-02-03 2000-05-31 Fideline, Le Rieu Neuf Eigenschaften von Gesichtpheromonen von Katzen
DE19511572C2 (de) * 1995-03-29 1998-02-26 Henkel Kgaa Niedrigviskose Trübungsmittelkonzentrate
DE19615777C2 (de) * 1996-04-20 1999-04-01 Henkel Kgaa Verwendung von Milchsäure-Milchsäureester-Mischungen
JP4754688B2 (ja) * 1998-01-21 2011-08-24 フィドゥラン ストレス、不安及び攻撃性を低減するブタ鎮静フェロモン

Also Published As

Publication number Publication date
BR9907151A (pt) 2000-10-24
DK1047415T3 (da) 2005-04-25
CA2227706A1 (en) 1999-07-21
IL137257A0 (en) 2001-07-24
JPH11209293A (ja) 1999-08-03
PL199144B1 (pl) 2008-08-29
DE69922633T2 (de) 2005-12-15
HU226882B1 (en) 2010-01-28
HUP0101312A3 (en) 2005-11-28
PT1047415E (pt) 2005-04-29
BRPI9907151C1 (pt) 2021-05-25
CA2318392A1 (en) 1999-07-29
WO1999037297A1 (en) 1999-07-29
PT948963E (pt) 2003-09-30
DK0948963T3 (da) 2003-08-11
DE69814343T2 (de) 2003-12-24
BRPI9907151B8 (pt) 2017-11-14
NO20003693L (no) 2000-09-20
NO980282L (no) 1999-07-22
EP0948963A1 (de) 1999-10-13
ZA99426B (en) 1999-07-21
AU760614B2 (en) 2003-05-22
SK10902000A3 (sk) 2001-02-12
NO20003693D0 (no) 2000-07-19
NO308197B1 (no) 2000-08-14
CZ20002700A3 (cs) 2000-12-13
CA2318392C (en) 2011-11-15
CN1291093A (zh) 2001-04-11
PL341867A1 (en) 2001-05-07
CA2227706C (en) 2010-08-03
ES2198661T3 (es) 2004-02-01
US6077867A (en) 2000-06-20
DE69814343D1 (de) 2003-06-12
CN1217659C (zh) 2005-09-07
US6384252B1 (en) 2002-05-07
EP1047415B1 (de) 2004-12-15
BRPI9907151B1 (pt) 2016-02-16
EP0948963B1 (de) 2003-05-07
NO980282D0 (no) 1998-01-21
ATE239464T1 (de) 2003-05-15
JP4750232B2 (ja) 2011-08-17
NO329205B1 (no) 2010-09-13
NZ505813A (en) 2003-07-25
EP1047415A1 (de) 2000-11-02
DE69922633D1 (de) 2005-01-20
ES2234236T3 (es) 2005-06-16
AU2423799A (en) 1999-08-09
HUP0101312A2 (hu) 2001-08-28
SK285905B6 (sk) 2007-10-04

Similar Documents

Publication Publication Date Title
ATE284688T1 (de) Feromone enthaltende zusammensetzung zur minderung von stress, angst und streitsucht in schweine
ES2127022T3 (es) Aditivos y composiciones de fueloleo.
DE69534801D1 (de) Neues lysin decarboxylase gen und verfahren zur herstellung von l-lysin
ATE321525T1 (de) Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis
DE60034919D1 (de) Kosmetische Zubereitung Ester hydroxylierter Fettsäuren enthaltend
DK0878997T3 (da) Spiselig vegetabilsk fedtstofsammensætning
DE59505676D1 (de) Synthetische ester aus alkoholen und fettsäuregemischen aus ölsäurereichen, stearinsäurearmen pflanzenölen
DE59808773D1 (de) Verwendung synthetischer Triglyceride auf Basis konjugierter Linolsäure zur Herstellung von Mitteln zur Behandlung von katabolischen Zuständen
DK657287A (da) Fremgangsmaade til kontinuerlig fraktionering af en blanding af fedtsyrer
ATE160378T1 (de) Verfahren zur herstellung von glykosid-estern und zusammensetzungen daraus
ES2118629T3 (es) Mezcla de grasas conteniendo fosfolipidos con acidos grasos lcp
ATE422216T1 (de) Mediumzusätze und medien für tierzellkulturen
DE69811676D1 (de) Verfahren zur verminderung des gehaltes an langkettigen gesättigten fettsäuren in fettsäurezusammensetzungen
DE59002572D1 (de) Omega-3-fettsäurenhaltige fettemulsion zur endotrachealen applikation, ihre herstellung und anwendung.
NZ505200A (en) Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
FR2604624B1 (fr) Nouvelles compositions cosmetiques ou dermatologiques riches en acides gras essentiels presents a la fois sous forme de triglycerides et sous forme libre ou salifiee
ATE228556T1 (de) An omega-3 ungesättigten fettsäuren angereicherte wachsester, ihre herstellung und verwendung
DE69818206D1 (de) Verfahren zur Herstellung von Cyanhydricarbonsäureestern und alpha-Hydroxycarbonsäuren
ATA260682A (de) Verfahren zur herstellung von glyoxylsaeure und von glyoxylsaeurealkylesterhalbacetalen
DE59803054D1 (de) Verfahren zur Herstellung von hellfarbigen Fettsäureniedrigalkylestern mit vermindertem Gehalt an freiem und gebundenem Glycerin
DK386479A (da) Fremgangsmaade til hydrolyse af maelkeaeggehvidestof i flydende tilstand med ikke-oxyderende mineralsyrer
EA199900570A1 (ru) Гипоталамо-гипофизарное средство, вызывающее устойчивую стадию торможения и/или покоя у собак и стадию покоя у кошек (анэструс)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1047415

Country of ref document: EP